Beyond treatment: Supporting quality of life, sexual health and recovery
Join Sophie Smith for a 20‑minute session focused on supporting quality of life, sexual health and recovery for men living with and beyond prostate cancer. Drawing on extensive clinical experience and her leadership in developing national support services, Sophie explores the impact of treatment on sexual function and wellbeing, how to initiate and normalise conversations about sexual health, and practical strategies for overcoming common barriers in secondary care. The session also highlights key guidelines and signposting pathways to help clinicians provide holistic, inclusive and person‑centred support.
Exercise as Medicine in prostate cancer: Lessons from Practice
Join Jo Riches, Gemma Harris, and Andy Westbrook for a practical 20‑minute session exploring how exercise functions as an evidence‑based intervention for men living with and beyond prostate cancer. Drawing on real‑world experience from clinical practice, service development, and lived experience, the session highlights the design and safety of Prostate Cancer UK’s exercise pilot programme, the gap between diagnosis and access to specialist support, and the role of clinician endorsement in improving engagement. Participants will gain clear guidance on referral pathways, patient suitability, and how exercise can reduce downstream healthcare demand.
Sexual Wellbeing: In conversation with Steve Allen
Join Kavita Taylor and Steve Allen for a powerful and honest conversation about sexual wellbeing after prostate cancer. Through Steve’s lived experience and Kavita’s expertise in service development and holistic support, this 20‑minute session explores the emotional, relational, and identity‑related impact of treatment‑related sexual side effects. The discussion highlights gaps in current support, the importance of compassionate, person‑centred care, and practical ways secondary care teams can strengthen sexual wellbeing pathways for men living with and beyond prostate cancer.
Optimising Prostate Cancer Survivorship: The Role of PDE5 Inhibitors
Join Professor Mike Kirby for a focused 20‑minute session exploring the evolving role of PDE5 inhibitors in prostate cancer survivorship. This session examines the burden and mechanisms of erectile dysfunction after treatment, emerging evidence for wider cardiovascular, metabolic, and urological benefits, and the implications for multidisciplinary follow‑up in secondary care. Participants will gain practical insights into prescribing challenges, patient selection, and how PDE5 inhibitors may support improved long‑term outcomes and quality of life for men living beyond prostate cancer.
Tomorrow’s tools Today: How AI is transforming prostate cancer care
Join Professor Nikhil Vasdev for a 20‑minute exploration of how artificial intelligence is reshaping prostate cancer care. This session highlights the real‑world applications of AI across the prostate cancer pathway — from enhanced diagnostic accuracy to nerve‑sparing surgical planning and improved perioperative care. Drawing on cutting‑edge research, clinical trials, and NHS implementation experience, Professor Vasdev will provide practical insights into how AI can improve outcomes, streamline services, and support more personalised, data‑driven care in secondary settings.
Structured, risk-stratified active surveillance: Lessons from implementing the STRATCANS approach
Join Andrew Seggie, Samantha McBeigh, and Claire Turner for a practical 35‑minute session exploring how structured, risk‑stratified active surveillance can be successfully implemented in secondary care. Drawing on the STRATCANS approach and real‑world experience from nurse‑led services across the UK, the session highlights how evidence‑based practice, strong clinical leadership, and effective cross‑departmental communication can transform active surveillance pathways. Participants will gain insights into overcoming implementation challenges, embedding consistent risk stratification, and using patient voice to redesign services that are safe, sustainable, and person‑centred.
Mind the gap: Tackling Inequalities in prostate cancer care
Join Dr Kukua Harley and Wayne Perkins for a powerful session exploring the inequalities that shape prostate cancer outcomes. Focusing on the heightened risk for Black men, systemic barriers across the prostate cancer pathway, and the importance of embedding the patient voice, this 30‑minute session highlights practical steps secondary care clinicians can take to deliver more equitable, culturally competent, and person‑centred care. Through clinical insight and lived experience, the session offers a grounded understanding of how to close the gap and improve outcomes for those most at risk.
Genes & Risk: What every Secondary Care Clinician should know about BRCA
Join Dr Liz Bancroft for a focused 30‑minute session on the essential BRCA knowledge every secondary care clinician should understand. This webinar explores the clinical significance of BRCA1 and BRCA2, the role of screening in carriers, the impact of BRCA status on prostate cancer treatment, and how to navigate NHS genetic testing pathways. The session also highlights the importance of genetic counselling and the wider implications for families, supporting clinicians to deliver informed, equitable, and patient‑centred care.
PRECISE Scoring: Enhancing Clinical Decision-Making
Dr Olly Hulson, Consultant Radiologist at Leeds Teaching Hospitals NHS Trust presents the role of MRI and the PRECISE criteria in active surveillance for prostate cancer.
Key Challenges in Active Surveillance – Insights and Solutions
Professor Vincent Gnanapragasam, Professor of Urology and Honorary Consultant Urologist, Professor Caroline Moore, NIHR Research Professor and Head of Urology at UCL and Andrew Seggie, Health Influencing Senior Officer- Earlier Diagnosis Lead at Prostate Cancer UK, present insights into improving active surveillance for prostate cancer.